AMLX - CIK 0001658551
Amylyx Pharmaceuticals, Inc. has filed 403 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (160 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2022-01-13 | 2022-01-11 |
| Employee stock plan | S-8 | 2022-01-12 | - |
| Major company event | 8-K | 2022-01-11 | 2022-01-11 |
| New insider ownership | 3 | 2022-01-11 | 2022-01-06 |
| 424B4 | - | 2022-01-10 | - |
| Insider trade | 4 | 2022-01-10 | 2022-01-06 |
| Insider trade | 4 | 2022-01-10 | 2022-01-06 |
| Insider trade | 4 | 2022-01-10 | 2022-01-06 |
| Insider trade | 4 | 2022-01-10 | 2022-01-06 |
| Insider trade | 4 | 2022-01-10 | 2022-01-06 |
| Insider trade | 4 | 2022-01-10 | 2022-01-06 |
| Insider trade | 4 | 2022-01-10 | 2022-01-06 |
| Insider trade | 4 | 2022-01-10 | 2022-01-06 |
| Insider trade | 4 | 2022-01-10 | 2022-01-06 |
| SEC STAFF LETTER | - | 2022-01-06 | - |
| EFFECT | - | 2022-01-06 | - |
| Exchange certification | CERT | 2022-01-06 | - |
| S-1MEF | - | 2022-01-06 | - |
| New insider ownership | 3 | 2022-01-06 | 2022-01-06 |
| New insider ownership | 3 | 2022-01-06 | 2022-01-06 |
| New insider ownership | 3 | 2022-01-06 | 2022-01-06 |
| New insider ownership | 3 | 2022-01-06 | 2022-01-06 |
| New insider ownership | 3 | 2022-01-06 | 2022-01-06 |
| New insider ownership | 3 | 2022-01-06 | 2022-01-06 |
| New insider ownership | 3 | 2022-01-06 | 2022-01-06 |
| New insider ownership | 3 | 2022-01-06 | 2022-01-06 |
| New insider ownership | 3 | 2022-01-06 | 2022-01-06 |
| Company correspondence | CORRESP | 2022-01-04 | - |
| Company correspondence | CORRESP | 2022-01-04 | - |
| 8-A12B | - | 2022-01-04 | - |
| Free writing prospectus | FWP | 2022-01-04 | - |
| S-1/A | - | 2022-01-03 | - |
| Company correspondence | CORRESP | 2021-12-16 | - |
| IPO registration | S-1 | 2021-12-16 | - |
| SEC correspondence | UPLOAD | 2021-12-09 | - |
| SEC STAFF LETTER | - | 2021-12-01 | - |
| DRS/A | - | 2021-11-26 | - |
| DRSLTR | - | 2021-11-24 | - |
| SEC correspondence | UPLOAD | 2021-11-23 | - |
| DRSLTR | - | 2021-10-20 | - |
| DRS/A | - | 2021-10-20 | - |
| SEC correspondence | UPLOAD | 2021-05-28 | - |
| DRS | - | 2021-04-26 | - |
| D | - | 2020-07-01 | - |
| D/A | - | 2020-01-28 | - |
| D/A | - | 2019-12-31 | - |
| D | - | 2019-12-31 | - |
| D | - | 2018-11-20 | - |
| D | - | 2017-08-04 | - |
| D/A | - | 2016-08-22 | - |